Women's Health Global Market Report 2025

Description

Women's health pertains to the area of medicine and healthcare dedicated to diagnosing, treating, and preventing diseases and conditions that uniquely impact women. This field covers various issues, including reproductive health, menstrual health, pregnancy and childbirth, menopause, and conditions like breast and ovarian cancers. It also tackles other health concerns that disproportionately affect women, such as osteoporosis, cardiovascular disease, and autoimmune disorders.

The primary categories of products related to women's health include devices, drugs, and pharmaceutical pipelines. Women's health devices are instrumental in treating medical conditions specific to women. This includes individuals aged 50 years and older, who may undergo hormonal treatment, non-hormonal treatment, and surgeries for a range of applications. These applications span postmenopausal osteoporosis, hormonal infertility, endometriosis, uterine fibroids, contraceptives, menopause, and polycystic ovary syndrome (PCOS). These women's health products are made available through various distribution channels, including hospitals, retail stores, and online pharmacies.

The women's health market research report is one of a series of new reports from The Business Research Company that provides women's health market statistics, including women's health industry global market size, regional shares, competitors with a women's health market share, detailed women's health market segments, market trends and opportunities, and any further data you may need to thrive in the women's health industry. This women's health market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The women's health market size has grown steadily in recent years. It will grow from $43.53 billion in 2024 to $45.5 billion in 2025 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to advancements in reproductive medicine, awareness and education initiatives, empowerment and advocacy movements, prenatal and postnatal care advances, development of hormone replacement therapies.

The women's health market size is expected to see strong growth in the next few years. It will grow to $58.07 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to precision medicine in gynecology, rise in female-focused clinical trials, expanded use of non-invasive prenatal testing, expanded access to fertility treatments, increasing focus on mental health. Major trends in the forecast period include digital health solutions, fertility tracking and reproductive health, non-hormonal contraceptive options, maternal health and pregnancy monitoring, innovations in women's health diagnostics, integration of artificial intelligence (ai).

The escalating prevalence of women-centric diseases stands as a significant driver propelling the growth trajectory of the women's health market. A surge in conditions such as anemia, osteoporosis, breast cancer, menopause, and others, attributed to diverse risk factors like family history, advancing age, early onset of menstruation or menopause post-55 years, obesity, among others, is fueling the demand for women's health products and services. These offerings cater to treating these diseases while prioritizing the overall health and wellness of women. For example, the American Cancer Society's report published in January 2023 highlighted cervical cancer's historical status as a leading cause of cancer-related deaths among American women. An estimated 13,960 new cases of invasive cervical cancer are projected to be diagnosed in the USA in 2023, with approximately 4,310 anticipated fatalities. Hence, the escalating incidence of women-centric diseases is steering the expansion of the women's health market.

An upsurge in the aging populace emerges as a significant catalyst propelling the advancement of the women's health market. The demographic shift towards an aging population, characterized by a burgeoning proportion of individuals aged 65 and above, necessitates an increased focus on women's health needs. Women within this demographic encounter a higher prevalence of diseases such as osteoporosis, breast cancer, and menopause-related issues. This demographic shift underscores the augmented demand for specialized women's health services and products. It accentuates the significance of preventive measures, screenings, and tailored healthcare interventions aimed at preserving the well-being and enhancing the quality of life for older women. Notably, the World Health Organization's October 2022 report predicts that by 2030, 1 in 6 individuals globally will be aged 60 years or older, with the population of people aged 60 years and older anticipated to double by 2050, reaching 2.1 billion. Thus, the burgeoning aging population significantly propels the women's health market.

Developments in women's health represent a significant trend within the women's health market. Leading companies in this sector are creating new products to bolster their market position. For example, in July 2022, GE Healthcare, a US-based medical technology firm, introduced the Voluson Expert 22. This new addition to the company's women's health portfolio utilizes graphic-based beam former technology, providing exceptional image quality and improved flexibility in imaging capabilities. The system is equipped with advanced tools powered by Artificial Intelligence (AI), ensuring greater consistency in examinations while minimizing the number of tasks needed.

Major players in the women's health market are integrating innovative technologies like Transcutaneous Electrical Nerve Stimulation (TENS) to solidify their position. TENS is a non-invasive therapeutic technique involving a battery-operated device that emits low-voltage electrical currents through electrode pads placed on specific body areas. This technology, exemplified by Myoovi's September 2023 launch in the UK, offers relief for painful menstruation cramps. By generating electrical signals, TENS interferes with and obstructs pain signals attempting to reach the brain, thereby minimizing pain. This drug-free alternative helps women manage the discomfort associated with menstrual cramps, offering a promising solution.

In March 2024, Halma, a UK-based technology firm, acquired Rovers Medical Devices (Rovers) for $92.63 million. This acquisition expands Halma's offerings in the women's health sector, specifically in cervical cancer diagnostics, and supports its objective of enhancing its position in cancer diagnosis products. Rovers Medical Devices, based in the Netherlands, specializes in designing and manufacturing sample collection devices intended for the diagnosis and prevention of cervical cancer.

Major companies operating in the women's health market are AbbVie Inc., Bayer AG, Merck & Co Inc., Pfizer Inc., Agile Therapeutics, Apothecus Pharmaceutical Corporation, Blairex Laboratories Inc., Novartis AG, AstraZeneca PLC, F. Hoffmann-La Roche Ltd., Ferring Pharmaceuticals, Lupin Pharmaceuticals Inc., Johnson & Johnson Services Inc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Hologic Inc., Celmatix Inc., HERA Biotech Inc., Juno Bio Inc., Maven Clinic Inc., MobileODT Ltd., Mylan N.V., ObsEva SA, Scailyte AG, Syrona Health AG

North America was the largest region in the women's health market in 2024. Asia-Pacific is expected to be the fastest-growing region in the women's health market report during the forecast period. The regions covered in the women's health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the women's health market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The women's health market consists of revenues earned by entities by providing hormone therapy, birth control treatment, and other related services. The market value includes the value of related goods sold by the service provider or included within the service offering. The women's health market also includes sales of contraceptive devices and pharmaceuticals, densitometry, breast implants, obstetrics or gynecology biopsy, imaging devices, and drugs such as Xgeva, Evista, Mirena, Zometa, Reclast, and Class, among others, that are used in providing women's health services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Women's Health Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on women's health market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for women's health ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The women's health market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product Type: Devices; Drugs; Pharmaceutical Pipeline
2) By Age: 50 Years & above ; Other Ages
3) By Treatment Type: Hormonal Treatment; Non-Hormonal Treatment; Surgeries
4) By Application: Postmenopausal Osteoporosis; Hormonal Infertility; Endometriosis & Uterine Fibroids; Contraceptives; Menopause; Polycystic Ovary Syndrome (PCOS)
5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Subsegments:
1) By Devices: Diagnostic Devices; Contraceptive Devices; Fertility Monitoring Devices; Gynecological Surgical Devices; Breast Pumps
2) By Drugs: Hormonal Therapies; Fertility Drugs; Osteoporosis Drugs; Menopause Treatment Drugs; Endometriosis Drugs; Contraceptives
3) By Pharmaceutical Pipeline: Emerging Drugs for Menopause; New Fertility Treatments; Novel Contraceptives; Drugs for Gynecological Conditions; Hormone Replacement Therapy Developments
Companies Mentioned: AbbVie Inc.; Bayer AG; Merck & Co Inc.; Pfizer Inc.; Agile Therapeutics
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r23081

1. Executive Summary

2. Women's Health Market Characteristics

3. Women's Health Market Trends And Strategies

4. Women's Health Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Women's Health Growth Analysis And Strategic Analysis Framework

5.1. Global Women's Health PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Women's Health Market Growth Rate Analysis
5.4. Global Women's Health Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Women's Health Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Women's Health Total Addressable Market (TAM)

6. Women's Health Market Segmentation

6.1. Global Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Devices
Drugs
Pharmaceutical Pipeline
6.2. Global Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
50 Years & above
Other Ages
6.3. Global Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hormonal Treatment
Non-Hormonal Treatment
Surgeries
6.4. Global Women's Health Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.5. Global Women's Health Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Postmenopausal Osteoporosis
Hormonal Infertility
Endometriosis & Uterine Fibroids
Contraceptives
Menopause
Polycystic Ovary Syndrome (PCOS)
6.6. Global Women's Health Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnostic Devices
Contraceptive Devices
Fertility Monitoring Devices
Gynecological Surgical Devices
Breast Pumps
6.7. Global Women's Health Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hormonal Therapies
Fertility Drugs
Osteoporosis Drugs
Menopause Treatment Drugs
Endometriosis Drugs
Contraceptives
6.8. Global Women's Health Market, Sub-Segmentation Of Pharmaceutical Pipeline, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Emerging Drugs for Menopause
New Fertility Treatments
Novel Contraceptives
Drugs for Gynecological Conditions
Hormone Replacement Therapy Developments

7. Women's Health Market Regional And Country Analysis

7.1. Global Women's Health Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Women's Health Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Women's Health Market

8.1. Asia-Pacific Women's Health Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Women's Health Market

9.1. China Women's Health Market Overview
9.2. China Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Women's Health Market

10.1. India Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Women's Health Market

11.1. Japan Women's Health Market Overview
11.2. Japan Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Women's Health Market

12.1. Australia Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Women's Health Market

13.1. Indonesia Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Women's Health Market

14.1. South Korea Women's Health Market Overview
14.2. South Korea Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Women's Health Market

15.1. Western Europe Women's Health Market Overview
15.2. Western Europe Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Women's Health Market

16.1. UK Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Women's Health Market

17.1. Germany Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Women's Health Market

18.1. France Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Women's Health Market

19.1. Italy Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Women's Health Market

20.1. Spain Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Women's Health Market

21.1. Eastern Europe Women's Health Market Overview
21.2. Eastern Europe Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Women's Health Market

22.1. Russia Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Women's Health Market

23.1. North America Women's Health Market Overview
23.2. North America Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Women's Health Market

24.1. USA Women's Health Market Overview
24.2. USA Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Women's Health Market

25.1. Canada Women's Health Market Overview
25.2. Canada Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Women's Health Market

26.1. South America Women's Health Market Overview
26.2. South America Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Women's Health Market

27.1. Brazil Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Women's Health Market

28.1. Middle East Women's Health Market Overview
28.2. Middle East Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Women's Health Market

29.1. Africa Women's Health Market Overview
29.2. Africa Women's Health Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Women's Health Market, Segmentation By Age, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Women's Health Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Women's Health Market Competitive Landscape And Company Profiles

30.1. Women's Health Market Competitive Landscape
30.2. Women's Health Market Company Profiles
- 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Agile Therapeutics Overview, Products and Services, Strategy and Financial Analysis

31. Women's Health Market Other Major And Innovative Companies

31.1. Apothecus Pharmaceutical Corporation
31.2. Blairex Laboratories Inc.
31.3. Novartis AG
31.4. AstraZeneca PLC
31.5. F. Hoffmann-La Roche Ltd.
31.6. Ferring Pharmaceuticals
31.7. Lupin Pharmaceuticals Inc.
31.8. Johnson & Johnson Services Inc.
31.9. Eli Lilly and Company
31.10. Teva Pharmaceutical Industries Ltd.
31.11. Hologic Inc.
31.12. Celmatix Inc.
31.13. HERA Biotech Inc.
31.14. Juno Bio Inc.
31.15. Maven Clinic Inc.

32. Global Women's Health Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Women's Health Market

34. Recent Developments In The Women's Health Market

35. Women's Health Market High Potential Countries, Segments and Strategies

35.1 Women's Health Market In 2029 - Countries Offering Most New Opportunities
35.2 Women's Health Market In 2029 - Segments Offering Most New Opportunities
35.3 Women's Health Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer